Onglets principaux

Rechercher
Limit to
Exporter 24 resultats:
Filtres: Auteur is David Lefebvre
2014
Application of a cell-based protease assay for testing inhibitors of picornavirus 3C proteases., van der Linden, Lonneke, Ulferts Rachel, Nabuurs Sander B., Kusov Yuri, Liu Hong, George Shyla, Lacroix Céline, Goris Nesya, Lefebvre David, Lanke Kjerstin H. W., et al. , Antiviral Res, 2014 Mar, Volume 103, p.17-24, (2014)
In vitro surrogate models to aid in the development of antivirals for the containment of foot-and-mouth disease outbreaks., Osiceanu, Ana-Maria, Murao Lyre Espada, Kollanur Denny, Swinnen Jan, De Vleeschauwer Annebel, Lefebvre David, De Clercq Kris, Neyts Johan, and Goris Nesya , Antiviral Res, 2014 May, Volume 105, p.59-63, (2014)
Proof of concept for the inhibition of foot-and-mouth disease virus replication by the anti-viral drug 2'-C-methylcytidine in severe combined immunodeficient mice., Lefebvre, David, De Vleeschauwer Annebel, Goris N, Kollanur D, Billiet A, Murao L, Neyts J, and De Clercq Kris , Transbound Emerg Dis, 2014 Dec, Volume 61, Issue 6, p.e89-91, (2014)
A thiazepino[4,5-a]benzimidazole derivative hampers the RNA replication of Eurasian serotypes of foot-and-mouth disease virus., Lefebvre, David, De Vleeschauwer Annebel, Goris Nesya, Van Borm Steven, Chimirri Alba, Monforte Anna Maria, Valdazo-Gonzalez Begona, King Donald P., Neyts Johan, and De Clercq Kris , Biochem Biophys Res Commun, 2014 Dec 12, Volume 455, Issue 3-4, p.378-81, (2014)

QR code

QR code for this page URL